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The activity of liposome-associated retinoic acid was analyzed on in vitro cultured tumor cell lines and compared to the antiproliferative ffects 
of free retinoic acid. It was found that liposome-associated retinoic acid is about 300 times more active than free retinoic acid in inhibiting in 
vitro cell growth of leukemic and melanoma cell lines. An increased activity of retinoic acid (l&20 times) was also obtained after premixing of 
this compound with empty liposomes, demonstrating that the retinoic acid efficiently interacts with liposomes which may facilitate solubility and 
cell uptake of retinoids. 
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1. INTRODUCTION 
Retinoids are a class of compounds of great interest, 
since they are powerful inducers of differentiation in a 
large variety of experimental systems [ 1,2] and strong 
inhibitors of proliferation of normal, as well as neo- 
plastic cells [2]. Among the clinical disadvantages of 
these compounds is the high toxicity (hypervitaminosis 
A) and long-lasting teratogenicity [3]. Retinoids bind to 
an extracellular RSBP and, after transfer to the cyto- 
plasmic compartment of the cells (by a process either 
spontaneous or mediated by a specific receptor) reti- 
noids bind to a CRABP [4]. This retinoid-CRABP com- 
plex is responsible for the activation of a limited set of 
eukaryotic genes [5]. 
leases [6,7]. In addition, liposomes could lead to an im- 
provement of the low water solubility of lipophilic 
drugs. With respect to retinoids, this latter feature 
could be of great interest, since the low water solubility 
is a problem for the administration of these com- 
pounds. 
Here we show that retinoic acid dramatically in- 
creases its antiproliferative effects toward tumor cell 
lines, when vehiculated with phospholipid vesicles. 
2. MATERIALS AND METHODS 
2.1. Liposome preparation 
In the attempt to find alternative ways to adminis- 
trate retinoids of possible therapeutical interest, we ex- 
plored the possibility to vehiculate retinoids to tumor 
cells by the use of liposomes. These vesicles could gener- 
ally be, indeed, a powerful tool for the vehiculation of 
drugs to target cells, since vesicles (i) decrease drug tox- 
icity; (ii) exhibit pharmacokinetics and bioavailability 
sharply different from those of the free drugs and (iii) 
can be functionalized by coupling either with mono- 
clonal antibodies or other signal molecules (glycopep- 
tides, hormones) leading to cell or tissue-specific re- 
MLV-REV made of egg PC and RA (abbreviated as MLV- 
REV(RA)) were prepared in a similar way as described elsewhere 181: 
50 mg of egg PC (Lipid Products, Surrey, England) dissolved in 2 ml 
chloroform-methanol (2: 1) and 0.7 mg of retinoic acid (Sigma, St. 
Louis, MO) in chloroform were dried in a 50 ml round bottom flask 
(retinoids/lipid molar ratio of 1: 25) under nitrogen using a rotatory 
evaporator. Residual solvent was removed under reduced pressure, 
and the resulting dried lipid-RA film was then dissolved in 2 ml of di- 
ethyl ether. To this solution, 4 ml of isotonic Palitzsch buffer [8] were 
added, and the buffer-lipid&A mixture was sonicated at 0°C for 
10 min in a Bandelin Sonorex TK52 bath sonicator under nitrogen. 
The ether present in the emulsion was then removed by rotary evapo- 
ration under reduced pressure at room temperature, resulting in a tur- 
bid, white liposome dispersion. Separation of liposome-associated 
RA from free RA was performed by gel filtration using a Sepharose 
4B column (Pharmacia, Uppsala, Sweden) (1.5 cm diameter, 50 cm 
length) [9]. 
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The UV/VIS spectrum of each fraction was measured both in iso- 
tonic Palitzsch buffer and in methanol in order to estimate the 
amount of liposome (from the turbidity at 600 nm) and in order to 
determine the concentration of RA (from the optical density of clear 
methanol solutions) at 351 nm, at the absorption maximum of RA. 
Empty MLV-REV were prepared in a similar way with the exception 
that the addition of the RA solution was omitted. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 293 
Volume 259, number 2 FEBS LETTERS January 1990 
2.2. Freeze fracture electronmicrographs 
Freeze fracture electronmicrographs were taken by Dr E. Wehrli at 
the Institute of Cell Biology of ETH, Zurich. The samples were frozen 
(from room temp~ature) by the propane-jet echnique [10,11], and 
the cryofiied preparations were fractured at 108K in a Balzen BAF 
300. The pressure was lo-* Pa. Platinum/carbon replicas were pro- 
duced and examined in a Philips EM 301 at 100 kV. Photomicro- 
graphs were taken on Agfa Scientia 23D56 cut films and developed in 
Geratone GSC for 3.5 min at 293K. 
2.3. ~eter~inat~o~ of effects on cell growth 
Effects of RA and MLV-REV(RA) were determined on the follow- 
ing in vitro cultured cell lines: the human leukemic KS62 [12], the 
murine erythroleukemia FLC [13] and the human melanoma Co10 38 
[14]. Standard conditions for cell growth were a-medium (Gibco, 
Grand Island, NY), 50 mg/l streptomycin, 300 mg/l penicillin, sup- 
plemented with IO-15% fetal calf serum (Flow Laboratories, 
McLean, VA) in 5% CO2 at 80% humidity. Cells were usually seeded 
at the initial densities of 10s cells/ml and counted with a Mode1 ZF 
Coulter Counter (Coulter Electronics, Hialeah, FL). 
3. RESULTS AND DISCUSSION 
3.1. Preparation of li~osome-associated ret~nojc acid 
Since retinoids are not water-soluble, we prefer the 
term ‘liposome-associated’ instead of the usually used 
term ‘liposome-entrapped’. In fact, it is likely that reti- 
noids are not solubilized into the internal aqueous 
space(s) of liposomes, but associated (intercalated) 
within the phospholipid bilayer(s). 
The preparation of liposome-associated RA has been 
performed by the reverse phase evaporation method 
[ 151. The corresponding elution profile of MLV- 
REV(RA) obtained after Sepharose4B chromatogra- 
phy is shown in fig.lA. One major peak, containing 
liposome~associated RA is present in the elution profile. 
This indicates that a high yield (over 95% of the total 
RA) of liposome-RA association is reached under these 
experimental conditions. This high yield is a direct 
evidence for interactions between RA and the PC mole- 
cules, as discussed above. The second and smaller peak 
in the chromatogram represents the elution of non- 
associated RA. 
The characterization of the MLV-REV(RA) present 
in the first peak was assessed by electron microscopy 
(fig. 1B). From this analysis, consistent with previously 
published results [ 153, it is obvious that the major com- 
ponents (over 85%) of the liposome preparation are 
large unilameliar vesicles; we, however, prefer to main- 
tain the denomination MLV-REV according to the 
preparation method. 
3.2. Comparisons of the antipro~iferative actjvity of 
RA, MLV-REV(RA) and empty h&V-REV 
In order to determine whether liposome-associated 
RA maintains or even enhances its in vitro antiprolifer- 
ative activity, K562 erythroleukemic ells were treated 
with the same amount (in terms of RA) of free or 
liposome-associated RA. Parallei control cultures of 
K562 cells were prepared by adding empty MLV-REV, 
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Fig. 1. (A) Elution profile of ~LV-REV(RA) on Sepharose 4B gel- 
filtration column (length, 50 cm; diameter, 1.5 cm; flow rate, 
160 &‘min, 3.2 ml/fraction). The MLV-REV were prepared by the 
reverse phase evaporation method (see section 2). The open triangle 
(v) indicates void volume fractions, including liposome-associated 
RA; the solid triangle (v) indicates fractions containing free RA. (B) 
Electron microscopy of a MLV-REV(RA) preparation by freeze- 
fracture analysis. Bar = 100 nm. 
at the same phospholipid concentrations used with 
MLV-REV(RA). After 5 days of cell culture, the cells 
were counted and the number of cells per milliliter were 
compared with the values obtained in the case of un- 
treated cells. 
Fig.2A indicates that the I&O is about 70 ,uM for free 
RA and 0.2 ,rrM for MLV-REV(RA); it is therefore sug- 
gested that MLV-REV(RA) exhibit a antiproliferative 
activity which is about 350 times higher than the activity 
of free RA. Empty MLV-REV do not cause any inhibi- 
tion of KS62 cell proliferation when used at PC concen- 
trations ranging from 0.05 to 1.6 mglml. The higher 
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Fig.2. (A) Effects of free RA (e), MLV-REV(RA) (T) and empty MLV-REV (m) on proliferation of K562 human erythromyeloid cells. Deter- 
minations were performed after 6 days of cell culture and represent he means f SD of 6 independent experiments (the empty and RA-associated 
vesicles were added at the same indicated concentrations of PC). (B-D) Differential antiproliferative activity of RA (filled symbols) and MLV- 
REV(RA) (open symbols) on murine erythroleukemic FL cells (B), human melanoma Co10 38 cells (C) and human erythromyeloid KS62 cells (D). 
Determinations were performed after 4 (B) and 6 (CD) days of cell culture. 
activity of MLV-REV(RA) with respect o free RA was 
consistently reproduced in six independent experiments 
(fig.2A) on K562 cells and was found to occur by using 
different tumor cell systems (fig.2B-D). 
3.3. Effects of empty iiposomes on RA-mediated 
inhibition of cell proliferation of iI762 ceils 
In order to determine whether addition of empty 
phospholipid vesicles retains effects on RA-mediated 
antiproliferative activity, increasing concentrations of 
free RA were premixed with different amounts of emp- 
ty MLV-REV and the effects on cell growth were deter- 
mined after 3 days of cell culture. The results obtained 
are shown in fig.3. When different concentrations 
(ranging from 6 to 1OOrM) of RA are premixed with 
different amounts of empty liposomes (with PC con- 
centrations ranging from 25 to 200 @g/ml) it is again 
evident that the association of empty liposomes with 
RA enhances the antiproliferative effects of RA toward 
K562 cells. 
3.4. Conclusions 
The main problems in chemotherapy of cancer pa- 
tients is the toxicity of the drugs employed, the lack of 
specific vehiculation of drugs and, in some instances, 
the solubility of drugs in the body fluids [I]. All of these 
disadvantages are a characteristic of most of the natural 
and synthetic retinoids proposed for therapy of a wide 
spectrum of pathologies, including proliferative der- 
matological pathologies and neoplastic diseases. In this 
study, we confirm recent published observations [16,17] 
showing that RA can be efficiently associated to lipo- 
somes . In addition, our results demonstrate that 
liposome-associated RA exhibits an improved in vitro 
antiproliferative effect compared to free RA. 
This increased effect could be due to an increased up- 
take and/or increased solubility of the retinoids. Ac- 
cordingly, retinoid transfer across and between phos- 
pholipid bilayer membranes has been suggested to oc- 
cur as a spontaneous and rather rapid process with a 
half-life of less than 30 s [ 161. In addition, retinol trans- 
fer between liposomes has also been characterized as a 
rapid process with a half-life of less than 10 min [la]. 
These results, when considered together with our data 
on: (i) the yield of RA-associated liposomes (fig.IA); 
and (ii) the effects on tumor cell proliferation (figs 2 
and 3), suggest that the interactions between liposomes 
and retinoids are a dynamic process. We suggest here- 
fore that retinoids exhibit a high affinity for phospho- 
lipids (fig.3). 
Fig.3. Effects of increasing concentrations of empty liposomes (0.2 
(0). 0.4 (B), 0.8 (A) and 1.6 (n) mg/ml of PC) on the antiprolifer- 
ative activity of RA. 0, no addition of empty liposomes. Determina- 
tions were performed on human er~hromyeloid KS62 cells after 6 
days of cell culture. 
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In conclusion, our results suggest that liposome- 
associated retinoids could be proposed: (i) for in vitro 
studies on the expression of the intracellular RA bind- 
ing protein; (ii) for the analysis of the effects on gene 
expression, especially focused on differentiating ex- 
perimental systems; and (iii) for in vivo treatment of 
animals after optimization of the Iiposomes with re- 
spect to stability in the blood circulation. The in vivo 
treatment of tumor-bearing animals is necessary in 
order to determine the possible applications of 
liposome-associated RA in experimental anticancer 
therapy. 
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